CATimelineAuthorisation object
General timespan (max nr days)
35
Mode of approval (General)
Tacit (Silent)
ATMP/GMO trials (max nr days)
90
Mode of approval (ATMP/GMO trials)
Explicit
Mode of approval (Xenogeneic cell therapy)
Not specified
Timespan counted from
Not specified
National legal framework in place
Yes
Applicable national legal framework/ Reference
Art 40 AMG
![This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395 This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395](/media/cms_page_media/2015/11/10/flag_yellow_low_100.jpg)